GSA Capital Partners’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

GSA Capital Partners’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-31,584	Closed	-$192K	–	1880
2019 Q2	$192K	Buy	+31,584	New	+$168K	0.02%	1249
2018 Q4	–	Sell	-36,627	Closed	-$711K	–	1927
2018 Q3	$711K	Buy	+36,627	New	+$780K	0.04%	895
2018 Q1	–	Sell	-40,450	Closed	-$812K	–	1938
2017 Q4	$812K	Buy	+40,450	New	+$795K	0.05%	697
2015 Q2	–	Sell	-6,500	Closed	-$225K	–	2285
2015 Q1	$225K	Buy	+6,500	New	+$177K	0.01%	1872

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GSA Capital Partners's DPLO Position: Q3 2019 in Review

GSA Capital Partners sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2019, closing a stake of 31,584 shares — an estimated $192K sold.

GSA Capital Partners first reported a position in DPLO in Q1 2015 and held it in 4 quarters. The position peaked at $812K in Q4 2017. 137 funds tracked by Wall St. Rank hold DPLO as of Q3 2019.

GSA Capital Partners reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2019 after selling out during the quarter.
GSA Capital Partners sold 31,584 DIPLOMAT PHARMACY, INC. shares in Q3 2019, an estimated $192K.
GSA Capital Partners first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 4 quarters.
GSA Capital Partners's DIPLOMAT PHARMACY, INC. position peaked at $812K in Q4 2017.
137 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2019.

Based on GSA Capital Partners's 13F filing for Q3 2019, filed 12 Nov 2019.